Reuters logo
2 个月前
BRIEF-Axsome Therapeutics receives FDA fast track designation for axs-05 for alzheimer’s disease agitation
2017年5月8日 / 上午11点27分 / 2 个月前

BRIEF-Axsome Therapeutics receives FDA fast track designation for axs-05 for alzheimer’s disease agitation

1 分钟阅读

May 8 (Reuters) - Axsome Therapeutics Inc

* Axsome therapeutics receives fda fast track designation for axs-05 for alzheimer’s disease agitation Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below